# OnCo record linnaeus-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/linnaeus-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "linnaeus-therapeutics" ;
  schema:name "Linnaeus Therapeutics"@en ;
  schema:alternateName "Linnaeus Therapeutics, Inc."@en ;
  schema:description "Linnaeus Therapeutics is a New Jersey biotech whose oral drug LNS8801 activates the oestrogen receptor GPER, a pathway that pushes melanoma cells to stop dividing and become visible to the immune system."@en ;
  schema:url <https://onco.cc/companies/linnaeus-therapeutics/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/lns8801/> .